ReGen Biologics Announces Results of FDA Appeal
14th Nov 2006, 15:40 GMT
ReGen Biologics has received a letter in which the FDA provided that ReGen may submit a new 510 for clearance of its collagen scaffold device with modified indications for use in the meniscus.
ReGen Biologics Announces Results of FDA Appeal related news:
- Dendreon Completes Submission of Biologics License Application to FDA for PROVENGE in Hormone Refractory Prostate Cancer — Government/ Industry Regulation News from StratCenter.com
- Dendreon Asks FDA to OK Prostate Drug — Government/ Industry Regulation News from StratCenter.com
- FDA Grants Priority Review for Soliris BLA for Treatment of Paroxysmal Nocturnal Hemoglobinuria — StratWire - Business of Healthcare NewsFeed
- North American Scientific Announces FDA Clearance of its ClearPath HDR Breast Brachytherapy System — FDA News News from StratCenter.com
- Novartis announces three-month extension of US regulatory review for Galvus® to assess recently available clinical data — WebWire - Recent Headlines
- / CORRECTION - Rosetta Resources Announces Third Quarter 2006 Financial and Operating Results — ArriveNet : Press Releases
- Human Pheromone Sciences Announces Q3 Results — StratWire - Business of Healthcare NewsFeed
- FDA should return to 'science-based' agency — News-Medical News Feed
- Cytori Announces 3rd Quarter Results: Update on Adipose Stem Cells in Cardiac Disease and Reconstructive Surgery — RedOrbit News - Health
- Cordia Corporation Announces Financial Results for the Third Quarter of 2006 — VoIP Developer
Latest news from Government/ Industry Regulation News from StratCenter.com:
- PLC Systems to Show RenalGuard at Medica 2006
- National Public Health Summit Targets Cervical Cancer Elimination
- MediPurpose Announces Exclusive Distribution Agreement for Sangofer Blood Separation Product
- Portrait PSR3 by Rhytec named in TIME Magazine's 2006 Skin Technology Story
- Pharsight Invited to Present on Model-Based Drug Development rd Annual Australian Health and Medical Research Congress
- Spectrum Pharmaceuticals Announces Presentation of Ozarelix Data at the Congress of the Societe Internationale d'Urologie
- Newly FDA Approved SmartLipo Laser Liposuction Available at the Intimate Rejuvenation and Innovative Surgery Center, Phoenix, AZ
- Sector Election Boosts Stem Cells
- AUDIO From Medialink and AARP: Voters' Call for Change Signals New Directions for Health Care
- Schering-Plough CEO Calls on New Congress to 'Do What Is Right' for the Patient, Calls for 'Scorecards' to Rate Managed Care Performance